Multimodal Theranostic Nanoparticles for Necrosis Targeting, Fluorescence/SPECT Imaging, and Radiotherapy of Residual Tumors after Hepatocellular Carcinoma Ablation-Reference-Cited by-同舟云学术

Multimodal Theranostic Nanoparticles for Necrosis Targeting, Fluorescence/SPECT Imaging, and Radiotherapy of Residual Tumors after Hepatocellular Carcinoma Ablation

Published:2024-03-07 Issue:4 Volume:21 Page:1729-1744
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Bao Han¹^ORCID,Wang Ning²,Chen Song³,Wang Yang⁴,Shao Haibo¹,Ni Yicheng⁵,Li Yukang¹,Liu Xian¹,Han Xiangjun¹^ORCID

Affiliation:

1. Department of Interventional Radiology, The First Hospital of China Medical University, Shenyang 110001, China

2. Department of Radiology, Shengjing Hospital of China Medical University, Shenyang 110001, China

3. Department of Nuclear Medicine, The First Hospital of China Medical University, Shenyang 110001, China

4. Department of Chemistry, School of Forensic Medicine, China Medical University, Shenyang 110122, China

5. Department of Radiology, Zhongda Hospital, Southeast University, Nanjing 210000, China

Funder

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.3c01081

Reference42 articles.

1. Percutaneous Ablation for Hepatocellular Carcinoma

2. Current role of microwave ablation in the treatment of small hepatocellular carcinomas

3. Liver resection for recurrent hepatocellular carcinoma after radiofrequency ablation therapy

4. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC

5. The local efficacy and influencing factors of ultrasound-guided percutaneous microwave ablation in colorectal liver metastases: a review of a 4-year experience at a single center

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovative hybrid nanostructures: pioneering advances in modern therapy;Frontiers in Nanotechnology;2024-08-29